Dhamane AD, Ajmera M, Meyers J, Davis KL. Treatment interruption patterns among adalimumab users in a commercially insured managed care population. Poster presented at the 2017 AMCP Managed Care & Specialty Pharmacy Annual Meeting; March 2017. Denver, CO. [abstract] J Manag Care Spec Pharm. 2017 Mar; 23(3a):S98.
Wang T, Meyers J, Davis K, Madhwani S, Boklage S. Patterns of H. pylori treatment and testing for patients in a commercially insured population. Poster presented at the 2015 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 1, 2015. San Diego, CA. [abstract] J Manag Care Pharm. 2015 Apr; 21(4-a):S11.
Loftus EV, Davis KL, Wang CC, Dastani H, Luo A. Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapy. Inflamm Bowel Dis. 2014 Aug;20(8):1361-7. doi: 10.1097/MIB.0000000000000089
Rubin DT, Mody R, Davis KL, Wang CC. Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease. Aliment Pharmacol Ther. 2014 May;39(10):1143-55. doi: 10.1111/apt.12727
Davis KL, Mody R, Patel H, Rubin DT. Association between Inadequate Response to Initial Treatment with Biologics and Health Care Costs in Patients with Inflammatory Bowel Disease. Poster presented at the 2014 AMCP 26th Annual Meeting & Expo; April 2014.
Davis KL, Wang E, Dastani H, Luo A, Loftus EV. Treatment patterns, complications, and disease relapse in a real-world population of moderate-to-severe ulcerative colitis patients initiating immunosuppressive therapy. Poster presented at the 2013 Digestive Disease Week; May 2013.
Davis KL, Mody R, Rubin DT, Wang E. Association between suboptimal therapy and health care costs in inflammatory bowel disease. Poster presented at the 2013 Digestive Disease Week; May 2013.
Candrilli S, Davis KL, Yen L. Characteristics of diverticulitis-related emergency department visits in the United States. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A328.
Davis KL, Mitra D, Yen L. Clinical characteristics, treatment patterns, and resource utilization in a real-world European population with diverticulitis. Poster presented at the 2012 ISPOR 15th Annual European Congress; November 9, 2012. Berlin, Germany. [abstract] Value Health. 2012 Nov; 15(7):A535-6.
Rubin DT, Mody R, Wang E, Davis KL. Assessment of therapy changes and drug discontinuation among crohn's disease patients using health claims data. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2012.
Mitra D, Hodgkins P, Yen L, Davis KL, Cohen RD. Association between oral 5-ASA adherence and health care utilization and costs among patients with active ulcerative colitis. BMC Gastroenterol. 2012 Sep 1;12(Sept):132.
Davis KL, Yen L, Loftus E, Hodgkins P. Pre-to-postdiagnosis increase in utilization and costs of chronic-use medications and other medical resources in managed care enrollees with diverticulitis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 6, 2012.
Davis KL, Yen L, Loftus EV, Hodgkins P. Pre- to post-diagnosis increase in utilization and costs of chronic-use medications and other medical resources in managed care enrollees with diverticulitis. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 1, 2012. Washington, DC. [abstract] Value Health. 2012 Jun; 15(4):A138.
Yen L, Davis KL, Candrilli S. The direct economic burden of diverticulitis recurrence among managed care enrollees. Poster presented at the 2012 ISPOR 17th Annual International Meeting; June 7, 2012. [abstract] Value Health. 2012 Jun; 15(4):A137-8.
Yen L, Davis KL, Hodgkins P, Loftus EVJr, Erder MH. Direct medical costs of diverticulitis in a US managed care population. Am J Manag Care. 2012;4(5):e118-29.
Loftus EV, Hodgkins P, Davis KL, Yen L. Economic burden of diverticulitis complications in a Unites States managed care population. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2011.
Mitra D, Davis KL, Baran RW. All-cause health care charges among managed care patients with constipation and comorbid irritable bowel syndrome. Postgrad Med. 2011 May 1;123(3):122-32.
Yen L, Davis KL, Longstreth G, Streck P, Hodgkins P. Resource utilization and health care costs associated with diverticular disease: results from a retrospective claims database analysis in the United States. Poster presented at the 2011 ISPOR 16th Annual International Meeting; May 2011. Baltimore, MD. [abstract] Value Health. 2011 May; 14(3):A183.
Yen L, Davis K, Longstreth G, Streck P, Hodgkins P. Resource utilization and health care costs associated with diverticulitis: results from a retrospective claims database analysis. Am J Gastroenterol. 2010 Oct 1;105(Suppl. 1):S431.
Iyer S, Davis KL, Candrilli S. Opioid use patterns and health care resource utilization in patients prescribed opioid therapy with and without constipation. Manag Care. 2010 Mar 1;19(3):44-51.
Debanjali M, Hodgkins P, Yen L, Solomon D, Davis KL, Cohen R. Adherence with oral 5-aminosalicylic acid therapy in patients with ulcerative colitis: impact on all-cause healthcare costs. Inflamm Bowel Dis. 2009 Dec 1;15(12):S32.
Mitra D, Hodgkins P, Yen L, Solomon D, Davis KL, Cohen RD. The impact of oral 5- ASA adherence on all-cause health care costs among ulcerative colitis patients. Poster presented at the Annual Scientific Meeting and Postgraduate Course of the American College of Gastroenterology; October 2009.
Mitra D, Davis KL, Hodgkins P, Yen L, Solomon D, Cohen RD. Assessing the relationship between adherence and health care costs: evidence from a managed care population with ulcerative colitis. Poster presented at the 31st Annual Meeting of the Society for Medical Decision Making; October 2009.
Candrilli SD, Davis KL, Iyer S. Impact of constipation on opioid use patterns, health care resource utilization, and costs in cancer patients on opioid therapy. J Pain Palliat Care Pharmacother. 2009 Sep 1;23(3):231-41.
Sikirica V, Bapat BS, Candrilli SD, Davis KL, Johns A. Inpatient care and expenditures associated with abdominal adhesiolysis in the United States in 2005. Poster presented at the VIIIth Pax meeting; September 2008.
Iyer S, Candrilli SD, Davis KL. Opioid use patterns, health care utilization, and costs in metastatic cancer patients on opioid therapy with constipation compared to patients without constipation. Poster presented at the Annual Meeting of the Canadian Pharmacists Association; June 2008.
Mitra D, Davis KL, Hodgkins P, Yan S. Adherence and utilization patterns with oral 5-aminosalicylates among patients with ulcerative colitis in a managed care population. Poster presented at the 20th Annual Meeting of the Academy of Managed Care Pharmacy; April 2008.
Iyer S, Candrilli SD, Davis KL. Patterns of opioid use, opioid-related side effects and resource utilization in cancer patients on chronic opioid therapy with constipation versus matched controls without constipation. Poster presented at the Scientific Symposium of the National Hospice and Palliative Care Organization; November 2007.
Mitra D, Davis KL, Baran RW. Healthcare costs and clinical sequelae associated with constipation in a managed care population. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2007.
Mitra D, Baran RW, Davis KL. Medical service and prescription drug charges before and after initial diagnosis among managed care patients with constipation. Poster presented at the Educational Conference of the Academy of Managed Care Pharmacy; October 2007.
Candrilli SD, Iyer S, Davis KL. Impact of constipation on health care utilization and costs in patients on opioid therapy. Poster presented at the 2007 ISPOR 10th Annual European Congress; October 2007. Dublin, Ireland.
Davis KL, Candrilli SD, Iyer S. Impact of constipation on resource utilization and costs in non-metastatic cancer patients on opioid therapy. Poster presented at the Annual Clinical Meeting of the American Academy of Pain Management; September 2007.
Iyer S, Candrilli SD, Davis KL. Opioid use patterns, health care utilization, and costs in metastatic cancer patients on chronic opioid therapy with constipation compared to patients without constipation. Poster presented at the 14th European Cancer Conference; September 2007.
Mitra D, Davis KL, Baran R. Health care utilization and costs associated with constipation (C-ONLY) and co-occurring irritable bowel syndrome and constipation (IBS+C) compared to migraine in a large managed care population. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A148-9.
Mitra D, Davis KL, Baran RW. Healthcare utilization and costs associated with constipation and co-occurring irritable bowel syndrome and constipation compared to matched controls in a large managed care population. Poster presented at the 2007 Digestive Disease Week; May 2007.
Mahajan S, Davis KL, Minnich M, Northcutt A, Bell T. The direct and indirect economic costs of irritable bowel syndrome in a large US employer population. Poster presented at the 2007 Digestive Disease Week; May 2007.